Procter & Gamble Co. 10-Q Summary
Business context and reporting period
The filing covers the quarter ended September 30, 2021, the first quarter of fiscal 2022, and compares results with the quarter ended September 30, 2020. P&G is a global consumer packaged goods company operating in Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care. Products are sold in more than 180 countries and territories, with operations in approximately 70 countries.
Financial performance and key metrics
| Metric | Q1 FY2022 | Q1 FY2021 | Change |
|---|---|---|---|
| Net sales | $20.338 billion | $19.318 billion | 5% |
| Operating income | $5.023 billion | $5.281 billion | (5%) |
| Net earnings | $4.126 billion | $4.308 billion | (4%) |
| Net earnings attributable to P&G | $4.112 billion | $4.277 billion | (4%) |
| Diluted EPS | $1.61 | $1.63 | (1%) |
| Operating cash flow | $4.643 billion | $4.739 billion | (2%) |
| Adjusted free cash flow | $3.777 billion | Not provided | Not provided |
Organic sales increased 4%, supported by 2% organic volume growth, 1% pricing, 1% favorable mix, and 1% favorable foreign exchange. Gross margin declined 370 basis points to 49.0%, primarily because of higher commodity costs, unfavorable mix, and increased restructuring charges. Operating margin declined 260 basis points to 24.7%, while net earnings margin declined 200 basis points to 20.3%. Adjusted free cash flow productivity was 92%, above the company’s long-term target of at least 90%.
As of September 30, 2021, cash and cash equivalents were $10.370 billion. Current liabilities exceeded current assets by $12.253 billion. Debt due within one year was $11.989 billion and long-term debt was $20.558 billion, for total reported debt of approximately $32.547 billion. Management expects operating cash flow, capital-market access, and credit facilities to support short-term liquidity and refinancing needs.
Capital expenditures were $1.091 billion. Financing activities used $3.428 billion, including $2.182 billion of dividends and $2.750 billion of treasury stock purchases. P&G repurchased approximately 19.4 million shares under publicly announced programs during the quarter. The company expects fiscal 2022 direct share repurchases of $7 billion to $9 billion, subject to change.
Material changes versus the prior comparable period
- Sales increased 5%, while operating income declined 5% because cost inflation and margin pressure more than offset sales growth.
- Commodity costs reduced gross margin by approximately 350 basis points. Transportation costs, product and packaging investments, and restructuring charges also pressured margins.
- SG&A increased 1% in dollars but declined to 24.3% of sales from 25.3%, reflecting scale benefits, productivity savings, and lower overhead ratios.
- Health Care delivered the strongest sales growth at 8%; Grooming, Beauty, and Fabric & Home Care each grew 5%; Baby, Feminine & Family Care grew 3%.
- Segment earnings increased in Grooming by 17%, Beauty by 2%, and Health Care by 1%, but declined in Fabric & Home Care by 12% and Baby, Feminine & Family Care by 18%.
- Other comprehensive income shifted to a $318 million loss from $289 million of income, primarily because of a $465 million foreign currency translation loss.
- Cash increased modestly to $10.370 billion from $10.288 billion at June 30, 2021, despite dividends, share repurchases, capital expenditures, and currency effects.
Guidance, outlook, commentary, risks, and unusual items
The filing does not provide a complete quantitative fiscal-year earnings or sales guidance update. Management stated that essential-product demand and strong credit ratings support liquidity, but future results remain subject to significant volatility.
- Management identified commodity, transportation, labor, energy, supply-chain, and other cost pressures as risks to gross margin, operating margin, earnings, and cash flow. Pricing and productivity actions may mitigate these pressures but could reduce consumer demand.
- COVID-19 had not materially negatively affected consolidated sales through the quarter, but the pandemic continued to create risks involving demand volatility, consumer pantry destocking, labor availability, transportation constraints, manufacturing disruptions, and future variants or restrictions.
- Foreign currency fluctuations, economic weakness, political instability, trade policies, tax-law changes, and regulatory requirements could affect sales and profitability.
- The Gillette indefinite-lived intangible asset remained particularly susceptible to impairment. Its carrying value was $14.1 billion, and management stated that reasonably possible adverse changes in discount rates, growth rates, or royalty rates could trigger an impairment. No triggering event was identified during the quarter.
- Litigation and environmental matters were not expected by management and counsel to materially affect financial position, results, or cash flows. The company has tax audits in approximately 40–50 jurisdictions and cannot reliably estimate the potential range of changes to uncertain tax positions.
- The company recorded a gain on the sale of operating real estate and benefited from a lower effective tax rate of 18.1%. Other non-operating income declined because of unrealized losses on equity investments.
- Disclosure controls were effective, and the filing reported no material changes in internal control over financial reporting.
Important facts for investors to verify
- Whether commodity, freight, labor, and supply-chain inflation continues to compress gross and operating margins despite pricing actions.
- Progress toward the stated $7 billion to $9 billion fiscal 2022 share-repurchase plan and its effect on share count, leverage, and liquidity.
- The maturity profile and refinancing requirements associated with approximately $32.5 billion of reported current and long-term debt.
- Whether the Gillette intangible asset and Shave Care goodwill remain above impairment thresholds as pandemic, category, currency, and discount-rate assumptions change.
- Whether organic volume growth and market-share gains can persist after pandemic-related comparisons, pricing increases, and potential consumer destocking.
- Future developments in COVID-19 conditions, foreign exchange, tax audits, litigation, environmental matters, and regulatory changes.